Literature DB >> 16377069

Preferential hydration and solubility of proteins in aqueous solutions of polyethylene glycol.

Ivan L Shulgin1, Eli Ruckenstein.   

Abstract

This paper is focused on the local composition around a protein molecule in aqueous mixtures containing polyethylene glycol (PEG) and the solubility of proteins in water+PEG mixed solvents. Experimental data from literature regarding the preferential binding parameter were used to calculate the excesses (or deficits) of water and PEG in the vicinity of beta-lactoglobulin, bovine serum albumin, lysozyme, chymotrypsinogen and ribonuclease A. It was concluded that the protein molecule is preferentially hydrated in all cases (for all proteins and PEGs investigated). The excesses of water and deficits of PEG in the vicinity of a protein molecule could be explained by a steric exclusion mechanism, i.e. the large difference in the sizes of water and PEG molecules. The solubility of different proteins in water+PEG mixed solvent was expressed in terms of the preferential binding parameter. The slope of the logarithm of protein (lysozyme, beta-lactoglobulin and bovine serum albumin) solubility versus the PEG concentration could be predicted on the basis of experimental data regarding the preferential binding parameter. For all the cases considered (various proteins, various PEGs molecular weights and various pHs), our theory predicted that PEG acts as a salting-out agent, conclusion in full agreement with experimental observations. The predicted slopes were compared with experimental values and while in some cases good agreement was found, in other cases the agreement was less satisfactory. Because the established equation is a rigorous thermodynamic one, the disagreement might occur because the experimental results used for the solubility and/or the preferential binding parameter do not correspond to thermodynamic equilibrium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377069     DOI: 10.1016/j.bpc.2005.11.010

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  7 in total

1.  Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability.

Authors:  Maria A Miller; Tarik A Khan; Kevin J Kaczorowski; Brian K Wilson; Aileen K Dinin; Ameya U Borwankar; Miguel A Rodrigues; Thomas M Truskett; Keith P Johnston; Jennifer A Maynard
Journal:  J Pharm Sci       Date:  2012-07-06       Impact factor: 3.534

2.  On the theory of solute solubility in mixed solvents.

Authors:  Paul E Smith; Robert M Mazo
Journal:  J Phys Chem B       Date:  2008-06-05       Impact factor: 2.991

3.  New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants.

Authors:  Sandra Herrmann; Silke Mohl; Florence Siepmann; Juergen Siepmann; Gerhard Winter
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.200

4.  Enhancing clot properties through fibrin-specific self-cross-linked PEG side-chain microgels.

Authors:  Nicole Welsch; Ashley C Brown; Thomas H Barker; L Andrew Lyon
Journal:  Colloids Surf B Biointerfaces       Date:  2018-03-02       Impact factor: 5.268

5.  Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment.

Authors:  Cristina Díaz-Barriga; Francisca Villanueva-Flores; Katrin Quester; Andrés Zárate-Romero; Ruben Dario Cadena-Nava; Alejandro Huerta-Saquero
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

6.  Molecular dynamics simulations on aqueous two-phase systems - Single PEG-molecules in solution.

Authors:  Stefan A Oelmeier; Florian Dismer; Jürgen Hubbuch
Journal:  BMC Biophys       Date:  2012-08-08       Impact factor: 4.778

7.  Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function.

Authors:  Jason Thomas Duskey; Federica da Ros; Ilaria Ottonelli; Barbara Zambelli; Maria Angela Vandelli; Giovanni Tosi; Barbara Ruozi
Journal:  Molecules       Date:  2020-10-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.